文献速递免疫规划传染病防控与疫情报告

中国江苏省将乙肝疫苗纳入扩大免疫规划12年后儿童乙型肝炎感染的最小化

Minimization of hepatitis B infection among children in Jiangsu, China, 12years after integration of hepatitis B vaccine into the expanded program on immunization.
PubMed 文献 · Vaccine · 2016-11-17

本研究调查中国江苏省2002至2014年出生儿童乙型肝炎病毒(HBV)的血清流行率及免疫水平,共纳入3442名7月龄至12岁儿童。结果显示12名(0.35%)儿童乙型肝炎表面抗原(HBsAg)阳性,2542名(73.85%)抗-HBs水平≥10mIU/ml;所有HBsAg阳性儿童均可检测到HBV DNA,未发现S基因a决定簇突变与疫苗失败相关。

要点

  • 江苏省2002至2014年出生儿童HBsAg阳性率为0.35%(12/3442)。
  • 73.85%(2542/3442)儿童抗-HBs水平≥10mIU/ml,15.54%(535/3442)为2-9.9mIU/ml。
  • 12名HBsAg阳性儿童均检测到HBV DNA,未发现S基因a决定簇突变与疫苗失败相关。

核心结论

  • 江苏省实施普遍乙肝疫苗接种后出生儿童的HBsAg流行率显著下降。
  • 在该儿童队列中未发现S基因突变与疫苗失败相关。

研究设计与样本

  • 研究纳入中国江苏省五个城市及农村地区2002至2014年出生的3442名7月龄至12岁儿童(男:女=2072:1370,年龄5.5±3.6岁)。
  • 采用ELISA和定量微粒子酶免疫分析法检测HBV标志物,实时PCR检测HBV DNA,巢式PCR扩增S区。

主要发现

  • 12名(0.35%)儿童HBsAg阳性,34名(0.99%)儿童HBsAg阴性且抗-HBc阳性。
  • 2542名(73.85%)儿童抗-HBs水平≥10mIU/ml,535名(15.54%)为2-9.9mIU/ml。
  • 所有12名HBsAg阳性儿童均可检测到HBV DNA,平均水平为6.1±1.7logIU/ml(范围3.3-8.1logIU/ml);8例为基因型C,4例为基因型B。
  • HBsAg a决定簇未检测到突变。
  • 全部34名抗-HBc阳性且HBsAg阴性儿童均未检测到HBV DNA。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: China has integrated hepatitis B vaccine into the Expanded Program on Immunization since 2002. We aimed to survey the seroprevalence of and immunity to hepatitis B virus (HBV) in children born from 2002 to 2014 in Jiangsu, China. METHODS: Totally 3442 children (M:F=2072:1370) at the age of 7months to 12years (5.5±3.6), from five cities and rural areas across Jiangsu province, were enrolled. Blood samples were measured for HBV markers by ELISA and quantitative microparticle enzyme immunoassay. HBV DNA was tested by real-time PCR and S region was amplified by nested PCR. RESULTS: Twelve (0.35%) children were positive for hepatitis B surface antigen (HBsAg) and 34 (0.99%) were HBsAg negative and positive for antibody against hepatitis B core antigen (anti-HBc). Totally 2542 (73.85%) children had anti-HBs levels ⩾10mIU/ml and 535 (15.54%) with 2-9.9mIU/ml. All 12 HBsAg-positive children had detectable HBV DNA with a mean level of 6.1±1.7logIU/ml (3.3-8.1logIU/ml); 8 were genotype C and 4 were genotype B. No mutation was detected in the a determinant of HBsAg. HBV DNA was not detected in all the 34 children with positive anti-HBc and negative HBsAg. CONCLUSION: HBsAg prevalence among children in Jiangsu born after the introduction of universal vaccination against hepatitis B has significantly decreased. No mutation of S gene is associated with vaccine failure in the cohort of children.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lin X, Yang J, Lu H, et al. Minimization of hepatitis B infection among children in Jiangsu, China, 12years after integration of hepatitis B vaccine into the expanded program on immunization. Vaccine. 2016. PMID: 27866767. doi:10.1016/j.vaccine.2016.11.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。